ArticleScientific reports2019
Utility of the Z-score of log-transformed A Body Shape Index (LBSIZ) in the assessment for sarcopenic obesity and cardiovascular disease risk in the United States.
Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Association between conicity index and osteoporosis/femoral bone mineral density in USA adults : a cross-sectional study based on evidence from the National Health and Nutrition Examination Survey (2005 to 2020).Bone & joint research · 2026Article
- A body shape index and sarcopenia risk in middle-aged and older adults: evidence from the China Health and Retirement Longitudinal Study.European journal of medical research · 2025Article
- The Triglyceride Glucose-Conicity Index as a Novel Predictor for Stroke Risk: A Nationwide Prospective Cohort Study.Journal of clinical medicine · 2025Article
- Variability in muscle function deficits and clinical identification of sarcopenic obesity in older adults with type 2 diabetes.Frontiers in medicine · 2025Article
- Knowledge, Attitude, and Belief of Healthcare Professionals Toward Obesity Stigmatization.Journal of multidisciplinary healthcare · 2025Article
- Elevated body roundness index increases the risk of cardiovascular disease in Chinese patients with circadian syndrome.Frontiers in endocrinology · 2025Article
- Correlation and predictive value of novel anthropometric indicators with adult sarcopenia and sarcopenia obesity.Scientific reports · 2024Article
- Relationship between Body Adiposity Indices and Reversal of Metabolically Unhealthy Obesity 6 Months after Roux-en-Y Gastric Bypass.Metabolites · 2024Article
- Associations of Body-Roundness Index and Sarcopenia with Cardiovascular Disease among Middle-Aged and Older Adults: Findings from CHARLS.The journal of nutrition, health & aging · 2023Article
- Conicity-index predicts all-cause mortality in Chinese older people: a 10-year community follow-up.BMC geriatrics · 2022Article
- Association between body shape index and risk of mortality in the United States.Scientific reports · 2022Article
- Association of X-ray Absorptiometry Body Composition Measurements with Basic Anthropometrics and Mortality Hazard.International journal of environmental research and public health · 2021Article
- Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes.Diabetes & metabolism journal · 2021Article
- The Association Between Sarcopenic Obesity and Hypertension, Diabetes, and Abnormal Lipid Metabolism in Chinese Adults.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- Dysregulation of Circulating miR-24-3p in Children with Obesity and Its Predictive Value for Metabolic Syndrome.Obesity facts · 2021Article
- A Comparison of Equation Córdoba for Estimation of Body Fat (ECORE-BF) with Other Prediction Equations.International journal of environmental research and public health · 2020Article
- Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity.Medicine · 2020Observational
- Association of Body Shape Index (ABSI) with Hand Grip Strength.International journal of environmental research and public health · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Body mass index (BMI) has limited accuracy for predicting cardiovascular diseases (CVD) and is not capable of identifying sarcopenic obesity, the combination of sarcopenia (an age-associated decline in muscle mass and physical function) and obesity. To overcome this, the z-score of the log-transformed A Body Shape Index (LBSIZ) was recently introduced as a measure of obesity using waist circumference, height, and weight. We aimed to investigate the association of LBSIZ with sarcopenic obesity and CVD, and propose appropriate cut-off values using the National Health and Nutrition Examination Survey 1999-2016 data. Of 92,062 participants, 40,468 adults (≥20 years) were included. Overall area under curve (AUC) of LBSIZ was 0.735 (95% confidence interval [CI]: 0.716-0.754) for sarcopenic obesity, and 0.695 (95% CI: 0.687-0.703) for CVD. The subgroup analysis of ethnicity/race showed similar results. Waist circumference (WC), BMI, conicity index, body roundness index (BRI), Clinica Universidad de Navarra-Body Adiposity Estimator (CUN-BAE), new BMI, and waist to height ratio (WHtR) showed a negative association with sarcopenic obesity, while LBSIZ and conicity index showed a positive association. The AUC of LBSIZ was significantly higher for sarcopenic obesity than that of conicity index (p < 0.001). The AUC of LBSIZ was significantly higher for CVD than those of parameters including WC, BMI, BRI, CUN-BAE, new BMI, and WHtR (p < 0.001). The AUC for conicity index alone was comparable to that of LBSIZ for CVD. Overall LBSIZ cut-off was 0.35 for both sarcopenic obesity (sensitivity, 65.3%; specificity, 71.5%) and CVD (sensitivity, 63.3%; specificity, 66.6%). These results may be useful not only to identify sarcopenic obesity, but also to conduct CVD risk assessment in the clinical setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.